Contribute Try STAT+ Today

Good morning, everyone. Damian Garde here, filling in for Ed Silverman on a sunny morning that bears at least a passing resemblance to autumn, behind schedule but welcome no less. Another day of deadlines, reply-alls, and just-circling-backs stands between you and that cherished weekend. To get you through, please find a few tidbits of news, and, as always, do stay in touch. …

COVAX, the ambitious global effort to vaccinate the world against Covid-19, has failed on its promise to efficiently deliver doses to low-income countries, according to The Bureau of Investigative Journalism and STAT. Diplomats report delayed deliveries and poor communication, leading some countries to abandon the program and order doses directly from manufacturers. COVAX has delivered only 300 million vaccines so far, well off its 2 billion target for 2021.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment